Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma (Q33346715)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma |
scientific article |
Statements
1 reference
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma (English)
1 reference
G C de Gast
1 reference
D Batchelor
1 reference
M J Kersten
1 reference
F A Vyth-Dreese
1 reference
J Sein
1 reference
W F van de Kasteele
1 reference
W J Nooijen
1 reference
O E Nieweg
1 reference
M A de Waal
1 reference
W Boogerd
1 reference
1 January 2003
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference